Wenfei Xia

426 total citations
13 papers, 268 citations indexed

About

Wenfei Xia is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Wenfei Xia has authored 13 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Wenfei Xia's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (4 papers). Wenfei Xia is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (4 papers). Wenfei Xia collaborates with scholars based in China. Wenfei Xia's co-authors include Xiao Hu, Yaying Du, Teng Cheng, Yun Liu, Lu Zhao, Xingrui Li, Yun Liu, Tao Xu, Menglu Dong and Zhifang Yang and has published in prestigious journals such as BMC Cancer, Journal of Experimental & Clinical Cancer Research and Frontiers in Endocrinology.

In The Last Decade

Wenfei Xia

11 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenfei Xia China 9 207 198 28 25 21 13 268
Jin‐Chun Qi China 10 181 0.9× 86 0.4× 23 0.8× 26 1.0× 43 2.0× 21 248
Xiubo Lu China 10 301 1.5× 317 1.6× 28 1.0× 10 0.4× 19 0.9× 14 391
Xiaolu Ge China 6 217 1.0× 194 1.0× 29 1.0× 18 0.7× 25 1.2× 9 270
Guozhi Yin China 13 275 1.3× 236 1.2× 58 2.1× 41 1.6× 39 1.9× 19 371
Shuting Tang China 5 93 0.4× 67 0.3× 19 0.7× 15 0.6× 20 1.0× 13 149

Countries citing papers authored by Wenfei Xia

Since Specialization
Citations

This map shows the geographic impact of Wenfei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfei Xia more than expected).

Fields of papers citing papers by Wenfei Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfei Xia. The network helps show where Wenfei Xia may publish in the future.

Co-authorship network of co-authors of Wenfei Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfei Xia. A scholar is included among the top collaborators of Wenfei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfei Xia. Wenfei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chen, Rui, Ying Zhou, Minzhi Xu, et al.. (2025). Association between multifactorial control and excess risk of liver diseases in type 2 diabetes: a prospective cohort study. BMJ Open Diabetes Research & Care. 13(5). e005336–e005336.
2.
Li, Hanning, Wenfei Xia, Teng Cheng, et al.. (2024). Long-term survival in a patient with metastatic parathyroid carcinoma harboring an EGFR sensitizing mutation: a case report. Journal of International Medical Research. 52(7). 3649320597–3649320597. 1 indexed citations
3.
Liu, Yun, Xiao Hu, & Wenfei Xia. (2023). Overexpression of Long Non-coding RNA uc.246 Facilitates Angiogenesis, Migration, and EMT Phenotype of Human Breast Cancer Cells. Applied Biochemistry and Biotechnology. 196(2). 1142–1153.
4.
5.
Xia, Wenfei, et al.. (2021). A Rapid Intraoperative Parathyroid Hormone Assay Based on the Immune Colloidal Gold Technique for Parathyroid Identification in Thyroid Surgery. Frontiers in Endocrinology. 11. 594745–594745. 22 indexed citations
6.
Xia, Wenfei, Yun Liu, Teng Cheng, et al.. (2020). Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1. Journal of Experimental & Clinical Cancer Research. 39(1). 18–18. 32 indexed citations
7.
Liu, Yun, Teng Cheng, Yaying Du, Xiao Hu, & Wenfei Xia. (2020). LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15. BMC Molecular and Cell Biology. 21(1). 69–69. 23 indexed citations
8.
Hu, Xiao, Yun Liu, Yaying Du, Teng Cheng, & Wenfei Xia. (2019). Long non-coding RNA BLACAT1 promotes breast cancer cell proliferation and metastasis by miR-150-5p/CCR2. Cell & Bioscience. 9(1). 14–14. 38 indexed citations
9.
Liu, Yun, Yaying Du, Xiao Hu, Lu Zhao, & Wenfei Xia. (2018). Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer. BMC Cancer. 18(1). 367–367. 60 indexed citations
10.
Du, Yaying, Wenfei Xia, Jinjun Zhang, et al.. (2017). Comprehensive analysis of long noncoding RNA–mRNA co-expression patterns in thyroid cancer. Molecular BioSystems. 13(10). 2107–2115. 22 indexed citations
11.
Xia, Wenfei, et al.. (2015). miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail. Oncology Reports. 34(2). 655–662. 40 indexed citations
12.
Zhang, Jing, Hua Jiang, Wenfei Xia, et al.. (2015). Serine-arginine protein kinase 1 is associated with hepatocellular carcinoma progression and poor patient survival. Tumor Biology. 37(1). 283–290. 9 indexed citations
13.
Xia, Wenfei, Xiaopeng Ma, Xingrui Li, et al.. (2014). Reversal effect of low‐intensity ultrasound on adriamycin‐resistant human hepatoma cells in vitro and in vivo. International Journal of Imaging Systems and Technology. 24(1). 23–28. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin‐Chun Qi Breakdown of academic impact, for papers by Xiubo Lu Breakdown of academic impact, for papers by Xiaolu Ge Breakdown of academic impact, for papers by Guozhi Yin Breakdown of academic impact, for papers by Shuting Tang
Rankless by CCL
2026